Scancell's CEO discusses her company's cancer immunotherapy programs
- blonca9
- May 3, 2024
- 1 min read
Lindy Durrant describes Scancell's DNA and peptide based vaccine programs, as well as early stage antibody work the company is doing for outlicensing to partners.